相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
Clinical Upstaging of Non-Small Cell Lung Cancer That Extends Across the Fissure: Implications for Non-Small Cell Lung Cancer Staging
Vijay Joshi et al.
ANNALS OF THORACIC SURGERY (2011)
Non-small cell lung cancer in never smokers: a clinical entity to be identified
Ilka Lopes Santoro et al.
CLINICS (2011)
Node-Negative Non-small Cell Lung Cancer Pathological Staging and Survival in 1765 Consecutive Cases
Benjamin M. Robinson et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
Caicun Zhou et al.
LANCET ONCOLOGY (2011)
Epidemiology of Lung Cancer: Smoking, Secondhand Smoke, and Genetics
Matthew A. Steliga et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2011)
Should we operate on microscopic N2 non-small cell lung cancer?
Eustace Fontaine et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2011)
Survival Comparison of Adenosquamous, Squamous Cell, and Adenocarcinoma of the Lung After Lobectomy
David T. Cooke et al.
ANNALS OF THORACIC SURGERY (2010)
Pack-Years of Cigarette Smoking as a Prognostic Factor in Patients With Stage IIIB/IV Nonsmall Cell Lung Cancer
Yelena Y. Janjigian et al.
CANCER (2010)
Long-term Survival Outcomes by Smoking Status in Surgical and Nonsurgical Patients With Non-small Cell Lung Cancer Comparing Never Smokers and Current Smokers
Robert A. Meguid et al.
CHEST (2010)
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
Federico Cappuzzo et al.
LANCET ONCOLOGY (2010)
The International Association for the Study of Lung Cancer Staging Project Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer
Kari Chansky et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Prognosis of smokers following resection of pathological stage I non-small-cell lung carcinoma
Noriyoshi Sawabata et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2007)
Smoking history before surgery and prognosis in patients with stage IA non-small-cell lung cancer - a multicenter study
H Kawai et al.
LUNG CANCER (2005)
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
T Le Chevalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mutations of the epidermal growth factor receptor gene in lung cancer:: Biological and clinical implications
T Kosaka et al.
CANCER RESEARCH (2004)
Modeling smoking history:: A comparison of different approaches
K Leffondré et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
分享论文
